0

Close
 
Upcoming Allied Market Research
2023
Clinical Laboratory Services Market

Clinical Laboratory Services Market

by Type (Clinical Chemistry, Medical Microbiology Cytology, Human Tumor Genetics, Other Esoteric Tests) and by Service Providers (Hospital-based Laboratories, Clinic-based Laboratories, Stand-alone Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A01312
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Clinical Laboratory Services Market

Request Now !

Clinical laboratories are an integral part of healthcare industry. All the diagnostic tests, which range from blood test to genetic analysis, are performed in these clinical laboratories to diagnose different diseases. Clinical laboratories give information and services, which contribute to maximize the necessary delivery in the healthcare system such as diagnostics and tests results. It assures and provides correct and accurate test results that enable physicians to make right therapeutic and diagnostic decisions through different levels of healthcare resources. It helps professionals to start, adjust, and also stop a course of treatment, which would be compromised in absence of clinical laboratory services.

Clinical laboratory services market is in emerging state due to the increase in incidence rate of diabetes, cancer, and other infectious diseases; as the number of patient pool increases, the demand for clinical laboratory services increases. Also, these services are cost-effective, and form the least invasive method for clinical decision making. These medical technologies provide flexibility in healthcare management by early diagnosis that improves disease treatment. In addition, introduction of new technologies that provide faster analysis, and are user-friendly contribute towards the market growth of clinical laboratory services. However, factors such as inadequate reimbursements, lack of skilled professionals, and stringent government policies impede the growth of the market.

The world clinical laboratory services market has been segmented based on type, service providers, and geography. Based on type, it is divided into clinical chemistry, medical microbiology & cytology, human & tumor genetics, and other esoteric tests. Based on service providers, the market is categorized into hospital-based laboratories, clinic-based laboratories, and stand-alone laboratories. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

Product launch, collaboration & merger, and acquisition are the key strategies adopted by market players. Healthcare giant such as Sonic Healthcare Limited has acquired Bioscientia Healthcare Group in August 2007 creating a high growth in clinical laboratory services market.

Comprehensive competitive analysis and profiles of major market players such as Siemens AG, Quest Diagnostics, Inc., Sonic Healthcare Limited, Abbott Laboratories, Cinven, Carlyle Group and TPG Capital, NeoGenomics, Inc., Sanofi S.A., OPKO Health, Inc. and Novartis International AG is also provided in this report.

KEY MARKET BENEFITS:

  • In-depth analysis is conducted based on market estimations of the key segments.
  • Comprehensive analysis of factors that drive and restrict the growth of the world clinical laboratory market is provided in the report.
  • Exhaustive analysis of the market by type and service providers helps understand different aspects of clinical laboratory that are currently used along with the variants that would gain prominence in future.
  • The key players along their growth strategies are provided to predict the competitive outlook of the market.
  • Analysis of current research and clinical developments within clinical laboratory market is provided with key dynamic factors that interpret the behavior of the market.

 Clinical Laboratory Services Market Report Highlights

Aspects Details
By Type
  • Clinical Chemistry
  • Medical Microbiology & Cytology
  • Human & Tumor Genetics
  • Other Esoteric Tests
By Service Providers
  • Hospital-based Laboratories
  • Clinic-based Laboratories
  • Stand-alone Laboratories
By Region
  • North America 
  • Europe 
  • Asia-Pacific 
  • LAMEA 
Key Market Players Abbott Laboratories, Quest Diagnostics, Inc., OPKO Health, Inc., Novartis International AG, Sonic Healthcare Limited, Carlyle Group and TPG Capital, Siemens AG, NeoGenomics, Inc., Cinven, Sanofi S.A.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CLINICAL LABORATORY SERVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Clinical Chemistry

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Medical Microbiology Cytology

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Human Tumor Genetics

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Other Esoteric Tests

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: CLINICAL LABORATORY SERVICES MARKET, BY SERVICE PROVIDERS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Service Providers

    • 5.2. Hospital-based Laboratories

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinic-based Laboratories

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Stand-alone Laboratories

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: CLINICAL LABORATORY SERVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Service Providers

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Clinical Laboratory Services Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Service Providers

      • 6.2.6. Canada Clinical Laboratory Services Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Service Providers

      • 6.2.7. Mexico Clinical Laboratory Services Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Service Providers

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Service Providers

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Clinical Laboratory Services Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Service Providers

      • 6.3.6. Germany Clinical Laboratory Services Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Service Providers

      • 6.3.7. Italy Clinical Laboratory Services Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Service Providers

      • 6.3.8. Spain Clinical Laboratory Services Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Service Providers

      • 6.3.9. UK Clinical Laboratory Services Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Service Providers

      • 6.3.10. Russia Clinical Laboratory Services Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Service Providers

      • 6.3.11. Rest Of Europe Clinical Laboratory Services Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Service Providers

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Service Providers

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Clinical Laboratory Services Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Service Providers

      • 6.4.6. Japan Clinical Laboratory Services Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Service Providers

      • 6.4.7. India Clinical Laboratory Services Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Service Providers

      • 6.4.8. South Korea Clinical Laboratory Services Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Service Providers

      • 6.4.9. Australia Clinical Laboratory Services Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Service Providers

      • 6.4.10. Thailand Clinical Laboratory Services Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Service Providers

      • 6.4.11. Malaysia Clinical Laboratory Services Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Service Providers

      • 6.4.12. Indonesia Clinical Laboratory Services Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Service Providers

      • 6.4.13. Rest of Asia Pacific Clinical Laboratory Services Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Service Providers

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Service Providers

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Clinical Laboratory Services Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Service Providers

      • 6.5.6. South Africa Clinical Laboratory Services Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Service Providers

      • 6.5.7. Saudi Arabia Clinical Laboratory Services Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Service Providers

      • 6.5.8. UAE Clinical Laboratory Services Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Service Providers

      • 6.5.9. Argentina Clinical Laboratory Services Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Service Providers

      • 6.5.10. Rest of LAMEA Clinical Laboratory Services Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Service Providers

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Siemens AG

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Quest Diagnostics, Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Sonic Healthcare Limited

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Abbott Laboratories

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Cinven

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Carlyle Group And TPG Capital

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. NeoGenomics, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Sanofi S.A.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. OPKO Health, Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Novartis International AG

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR MEDICAL MICROBIOLOGY CYTOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR HUMAN TUMOR GENETICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR OTHER ESOTERIC TESTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR CLINIC-BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CLINICAL LABORATORY SERVICES MARKET FOR STAND-ALONE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA CLINICAL LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 14. U.S. CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 16. CANADA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. CANADA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE CLINICAL LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 27. ITALY CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. ITALY CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 31. UK CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UK CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC CLINICAL LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 40. CHINA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. CHINA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 44. INDIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA CLINICAL LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 67. UAE CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UAE CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA CLINICAL LABORATORY SERVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA CLINICAL LABORATORY SERVICES, BY SERVICE PROVIDERS, 2022-2032 ($MILLION)
  • TABLE 73. SIEMENS AG: KEY EXECUTIVES
  • TABLE 74. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 75. SIEMENS AG: OPERATING SEGMENTS
  • TABLE 76. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 77. SIEMENS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. QUEST DIAGNOSTICS, INC.: KEY EXECUTIVES
  • TABLE 79. QUEST DIAGNOSTICS, INC.: COMPANY SNAPSHOT
  • TABLE 80. QUEST DIAGNOSTICS, INC.: OPERATING SEGMENTS
  • TABLE 81. QUEST DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 82. QUEST DIAGNOSTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. SONIC HEALTHCARE LIMITED: KEY EXECUTIVES
  • TABLE 84. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
  • TABLE 85. SONIC HEALTHCARE LIMITED: OPERATING SEGMENTS
  • TABLE 86. SONIC HEALTHCARE LIMITED: PRODUCT PORTFOLIO
  • TABLE 87. SONIC HEALTHCARE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 89. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 90. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 91. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 92. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. CINVEN: KEY EXECUTIVES
  • TABLE 94. CINVEN: COMPANY SNAPSHOT
  • TABLE 95. CINVEN: OPERATING SEGMENTS
  • TABLE 96. CINVEN: PRODUCT PORTFOLIO
  • TABLE 97. CINVEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. CARLYLE GROUP AND TPG CAPITAL: KEY EXECUTIVES
  • TABLE 99. CARLYLE GROUP AND TPG CAPITAL: COMPANY SNAPSHOT
  • TABLE 100. CARLYLE GROUP AND TPG CAPITAL: OPERATING SEGMENTS
  • TABLE 101. CARLYLE GROUP AND TPG CAPITAL: PRODUCT PORTFOLIO
  • TABLE 102. CARLYLE GROUP AND TPG CAPITAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. NEOGENOMICS, INC.: KEY EXECUTIVES
  • TABLE 104. NEOGENOMICS, INC.: COMPANY SNAPSHOT
  • TABLE 105. NEOGENOMICS, INC.: OPERATING SEGMENTS
  • TABLE 106. NEOGENOMICS, INC.: PRODUCT PORTFOLIO
  • TABLE 107. NEOGENOMICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. SANOFI S.A.: KEY EXECUTIVES
  • TABLE 109. SANOFI S.A.: COMPANY SNAPSHOT
  • TABLE 110. SANOFI S.A.: OPERATING SEGMENTS
  • TABLE 111. SANOFI S.A.: PRODUCT PORTFOLIO
  • TABLE 112. SANOFI S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. OPKO HEALTH, INC.: KEY EXECUTIVES
  • TABLE 114. OPKO HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 115. OPKO HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 116. OPKO HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 117. OPKO HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. NOVARTIS INTERNATIONAL AG: KEY EXECUTIVES
  • TABLE 119. NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT
  • TABLE 120. NOVARTIS INTERNATIONAL AG: OPERATING SEGMENTS
  • TABLE 121. NOVARTIS INTERNATIONAL AG: PRODUCT PORTFOLIO
  • TABLE 122. NOVARTIS INTERNATIONAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CLINICAL LABORATORY SERVICES MARKET
  • FIGURE 3. SEGMENTATION CLINICAL LABORATORY SERVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CLINICAL LABORATORY SERVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLINICAL LABORATORY SERVICES MARKET
  • FIGURE 11. CLINICAL LABORATORY SERVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. CLINICAL LABORATORY SERVICES MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CLINICAL LABORATORY SERVICES MARKET FOR MEDICAL MICROBIOLOGY CYTOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CLINICAL LABORATORY SERVICES MARKET FOR HUMAN TUMOR GENETICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. CLINICAL LABORATORY SERVICES MARKET FOR OTHER ESOTERIC TESTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CLINICAL LABORATORY SERVICES MARKET SEGMENTATION, BY BY SERVICE PROVIDERS
  • FIGURE 17. CLINICAL LABORATORY SERVICES MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. CLINICAL LABORATORY SERVICES MARKET FOR CLINIC-BASED LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CLINICAL LABORATORY SERVICES MARKET FOR STAND-ALONE LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: CLINICAL LABORATORY SERVICES MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. SIEMENS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. SIEMENS AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. SIEMENS AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. QUEST DIAGNOSTICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. QUEST DIAGNOSTICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. QUEST DIAGNOSTICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. SONIC HEALTHCARE LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. SONIC HEALTHCARE LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. SONIC HEALTHCARE LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. CINVEN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. CINVEN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. CINVEN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. CARLYLE GROUP AND TPG CAPITAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. CARLYLE GROUP AND TPG CAPITAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. CARLYLE GROUP AND TPG CAPITAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. NEOGENOMICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. NEOGENOMICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. NEOGENOMICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. SANOFI S.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. SANOFI S.A.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. SANOFI S.A.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. OPKO HEALTH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. OPKO HEALTH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. OPKO HEALTH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. NOVARTIS INTERNATIONAL AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. NOVARTIS INTERNATIONAL AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. NOVARTIS INTERNATIONAL AG: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Clinical Laboratory Services Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers